Parkinson's disease is not associated with the combined α-synuclein/apolipoprotein E susceptibility genotype: Parkinson's Disease and α-Synuclein Gene

Annals of Neurology

Volumn 49, Issue 5, 2001, Pages 665-668

  Khan, Naheed ^a,b   Graham, Elizabeth ^a,b   Dixon, Peter ^a,b   Morris, Christopher ^c   Mander, Adrian ^d   Clayton, David ^d   Vaughan, J ^a   Quinn, Niall ^b   Lees, Andrew ^b,e   Daniel, Susan ^b   Wood, Nicholas ^a,b   De Silva, Rohan ^a,e  

^a Neurogenetics Group   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; APOLIPOPROTEIN E; DINUCLEOTIDE; DNA;

ADULT; AGED; ARTICLE; CHROMOSOME 4Q; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; GENE; GENOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ALLELES; ALPHA-SYNUCLEIN; APOLIPOPROTEINS E; CHROMOSOMES, HUMAN, PAIR 4; FEMALE; GENETIC MARKERS; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; PARKINSON DISEASE; POLYMORPHISM, GENETIC; SYNUCLEINS;

EID: 18544406092     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.1027     Document Type: Article

References (17)

1. De Rijk M, Tzourio C, Breteler M, et al. Prevalence of parkinsonism and Parkinson's disease in Europe. J Neurol Neuropsychiatry 1997;62:10-15.
2. de Silva HAR, Khan N, Wood N. The genetics of Parkinson's disease. Curr Opin Genet Dev 2000;10:235-334.
3. Strachan T, Read A. Human molecular genetics. Oxford: BIOS Scientific, 1999;286-287.
4. Krüger R, Menezes A, Saecker V, et al. Increased susceptibility to sporadic Parkinson's disease by a certain combined α-synuclein/ apolipoprotein E genotype. Ann Neurol 1999;45:1-7.
5. Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997;276:2045-2047.
6. Krüger R, Kuhn W, Müller T, et al. Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease. Nat Genet 1998;18:106-108.
7. Spillantini MG, Schmidt ML, Lee VM, et al. α-Synuclein in Lewy bodies. Nature 1997;388:839-840.
8. Gibb WRG, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988;51:745-752.
9. Xia Y, de Silva HAR, Rosi BL, et al. Genetic studies in Alzheimer's disease with an NACP/α-synuclein polymorphism. Ann Neurol 1996;40:207-215.
10. Wenham PR, Price WH, Blundell G. Apolipoprotein E geno-typing by one-stage PCR. Lancet 1991;337:1158-1159.
11. Sham P, Curtis D. Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet 1995;59;97-105.
12. Chiano M, Clayton D. Fine genetic mapping using haplotype analysis and the missing data problem. Ann Hum Genet 1998; 62:55-60.
13. Gambaro G, Anglani F, D'Angelo A. Association studies of genetic polymorphisms and complex disease. Lancet 2000;355: 308-311.
14. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinicopathologic study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55: 181-184.
15. Eaves IA, Merriman T, Barber R, et al. The genetically isolated populations of Finland and Sardinia may not be a panacea for linkage disequilibrium mapping of common disease genes. Nat Genet 2000;25:320-323.
16. Taillon-Miller P, Bauer-Sardina I, Saccone NL, et al. Juxtaposed regions of extensive and minimal linkage disequilibrium in human Xq25 and Xq28. Nat Genet 2000;25:324-328.
17. Collins FS, Patrinos A, Jordan E, et al. New goals for the U.S. Human Genome Project: 1998-2003. Science 1998 23;282: 682-689.